Concepedia

Author

Brian Parkin

University of MichiganORCID

Also Known As

B Parkin, Brian L. Parkin, Brian Parkin

128

Publications

1.3K

Citations

20

H-Index

40

Concepts

All Affiliations

University of MichiganMichigan MedicineUniversity of Alabama at BirminghamDana-Farber Cancer InstituteUniversity of Colorado Anschutz Medical Campus
BP

About

Brian Parkin is an author at University of Michigan specializing in medicine, transplantation, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

241

2

Blood Transplantation

3

3

85

3

Cell Biology

2

2

81

4

Health Sciences

1

1

23

5

Natural Sciences

1

1

15

Brian Parkin

×

22

Publications

1.1K

Citations

18

H-Index

YearCitations

Activating STAT6 mutations in follicular lymphoma

Hongxiu Li, Denzil Bernard, Nisar A. Amin,

Blood

2014

139

Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia

Brian Parkin, Peter Ouillette, Yifeng Li,

Blood

2012

115

α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease

John Magenau, Steven C. Goldstein, Dan Peltier,

Blood

2018

109

Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia

Jianting Long, Brian Parkin, Peter Ouillette,

Blood

2010

82

Aggressive Chronic Lymphocytic Leukemia with Elevated Genomic Complexity Is Associated with Multiple Gene Defects in the Response to DNA Double-Strand Breaks

Peter Ouillette, Samuel Fossum, Brian Parkin,

Clinical Cancer Research

2010

73

Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia

Brian Parkin, Harry P. Erba, Peter Ouillette,

Blood

2010

70

Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT

Sung Won Choi, Thomas Braun, Israel Henig,

Blood

2017

67

A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia

Nisar A. Amin, Erlene Seymour, Kamlai Saiya-Cork,

Clinical Cancer Research

2016

66

FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML

Yan Song, John Magenau, Y Li,

Bone Marrow Transplantation

2015

50

Ultrasensitive mutation detection identifies rare residual cells causing acute myelogenous leukemia relapse

Brian Parkin, Angelina I. Londoño-Joshi, Qing Kang,

Journal of Clinical Investigation

2017

43

Page 1